Transcription of 32 1.4 Stability Workshpo ICH Q1D C - IKEV
{{id}} {{{paragraph}}}
ICHQ1D C ICH Q1D Guideline Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products ICH Step 4 Comments for its application ICHQ1D C 43 1. Introduction Objectives of the Guideline Recommendations for application of bracketing and matrixing Background Q1A(R2) mentions only possibility Scope of the Guideline Guidance on study designs Specific priniciples for applications Sample designs for illustrative purposes 2. Guidelines General Full study design: samples for every combination, all design factors tested at all time points Reduced design ability to adequately predict retest period or shelf life Risk assessment, shorter shelf life possible Change to full testing or less reduced design can be considered.
ICHQ1D C 44 2.3.1 Design Factors • Design factors are variables to be evaluated for their effect on product stability 2.3.1.1 Strengths
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Stability Testing of Pharmaceutical, STABILITY, Stability testing of active pharmaceutical, Stability Analysis of Voltage-Feedback, GUIDELINES ON STABILITY EVALUATION OF, Q1A(R2) Guideline Stability Testing of New, STABILITY – WHAT IS IT AND, SODIUM HYPOCHLORITE, Stability Testing of Pharmaceutical Products, Of packaging material on Pharmaceutical